Skip to main content
. 2024 Oct 15;16(10):e71555. doi: 10.7759/cureus.71555

Table 1. Patient characteristics.

APACHE Ⅱ, Acute Physiology and Chronic Health Evaluation Ⅱ; SOFA, Sequential Organ Failure Assessment; CKRT, Continuous Kidney Replacement Therapy; PMX-DHP, direct hemoperfusion using polymyxin B-immobilized fiber column; IABP, Intra-Aortic Balloon Pumping; Impella®️, percutaneous ventricular assist device; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; BT, body temperature; RR, respiratory rate; SpO2, saturation of percutaneous oxygen; GCS, Glasgow Coma Scale; P/F, partial pressure of arterial oxygen/fraction of inspiratory oxygen ratio; PaCO2, partial pressure of arterial carbon dioxide; HFNC, high-flow nasal cannula

- Overall (n = 1,400) Readmission group (n = 113) Non-readmission group (n = 1,287) P-value
Demographic data        
Age (years), median (IQR) 68 (56-76) 70 (59-77) 68 (56-76) 0.318
Male, n (%) 836 (59.7) 74 (65.5) 762 (59.2) 0.238
Clinical characteristics        
Charlson Comorbidity Index, median (IQR) 5 (3-6) 5 (3-7) 5 (3-6) 0.460
APACHE II, median (IQR) 18 (15-22) 19 (16-23) 18 (15-21) 0.002
SOFA at ICU admission, median (IQR) 6 (4-8) 7 (5-10) 6 (4-8) <0.001
ICU length of stay (days), median (IQR) 3 (2-6) 4 (2-8) 3 (2-6) 0.002
Mortality for 28 days 65 (4.6) 11 (9.7) 54 (4.2) 0.014
ICU admission source
Medical, n (%) 797 (56.9) 79 (69.9) 718 (55.8) 0.005
Surgical, n (%) 603 (43.1) 34 (30.1) 569 (54.2) 0.005
Reasons for ICU admission
Sepsis, n (%) 256 (18.3) 28 (24.8) 228 (17.2) 0.082
Cardiovascular surgery, n (%) 195 (13.9) 13 (11.5) 182 (14.1) 0.526
Other surgery, n (%) 405 (28.9) 21 (18.6) 384 (29.8) 0.015
Respiratory failure, n (%) 220 (15.7) 29 (25.7) 191 (14.8) 0.004
Circulatory failure, n (%) 145 (10.4) 11 (9.7) 134 (10.4) 0.948
Cerebrovascular disease, n (%) 24 (1.7) 1 (0.9) 23 (1.8) 0.741
Acute kidney injury, n (%) 59 (4.2) 1 (0.9) 58 (4.5) 0.111
Acute pancreatitis, n (%) 31 (2.2) 4 (3.5) 27 (2.1) 0.506
Endocrine disease, n (%) 67 (4.8) 3 (2.7) 64 (5.0) 0.381
Liver failure, n (%) 27 (1.9) 5 (4.4) 22 (1.7) 0.097
Metabolic disorder, n (%) 16 (1.1) 1 (0.9) 15 (1.2) 1.000
Treatment variables of the group
Mechanical ventilation, n (%) 757 (54.1) 65 (57.5) 692 (53.8) 0.503
Ventilator days, median (IQR) 1.0 (0-3.0) 2.0 (0-5.3) 1.0 (0-3.0) 0.006
CKRT, n (%) 253 (18.1) 36 (31.9) 217 (16.9) <0.001
PMX-DHP, n (%) 74 (5.3) 10 (8.8) 64 (5.0) 0.122
IABP, n (%) 30 (2.1) 0 (0) 30 (2.3) 0.193
Impella®️, n (%) 7 (0.5) 1 (0.9) 6 (0.5) 1.000
Tracheal suctioning, n (%) 184 (13.1) 30 (26.5) 154 (12.0) <0.001
Use of catecholamine, n (%) 51 (3.6) 5 (4.4) 46 (3.5) 0.841
Low-flow oxygen therapy, n (%) 946 (67.6) 82 (72.6) 864 (67.1) 0.281
HFNC, n (%) 86 (6.1) 3 (2.7) 83 (6.5) 0.160
Parameters at ICU discharge
SBP (mmHg), median (IQR) 121 (108-135) 123 (108-139) 121 (108-135) 0.457
DBP (mmHg), median (IQR) 69 (60-79) 69 (60-83) 69 (60-78) 0.906
HR (bpm), median (IQR) 83 (72-96) 89 (80-102) 82 (72-95) <0.001
BT (℃), median (IQR) 37.0 (37.0-37.8) 37.2 (37.0-38.0) 37.0 (36.9-37.7) 0.006
RR (bpm), median (IQR) 19 (16-22) 21 (17-25) 19 (16-22) <0.001
SpO2 (%), median (IQR) 98 (96-99) 97 (96-98) 98 (96-99) 0.003
GCS, median (IQR) 15 (14-15) 14 (12-15) 15 (14-15) <0.001
Cold extremities, n (%) 124 (8.9) 37 (32.7) 87 (6.8) <0.001
P/F, median (IQR) 357 (269-438) 333 (238-397) 358 (274-443) 0.004
PaCO2 (mmHg), median (IQR) 37.0 (34.0-41.0) 36.0 (34.2-41.3) 37.0 (34.0-41.0) 0.514
pH, median (IQR) 7.43 (7.40-7.47) 7.44 (7.41-7.48) 7.43 (7.40-7.47) 0.059
Sleep disturbance, n (%) 265 (18.9) 72 (63.7) 193 (15.0) <0.001
Delirium, n (%) 116 (8.3) 11 (9.7) 91 (7.1) 0.342
Reason for ICU readmission
Respiratory failure, n (%) - 46 (40.7) - -
Circulatory failure, n (%) - 35 (31.0) - -
Renal failure, n (%) - 13 (11.5) - -
Electrolyte disturbances, n (%) - 10 (8.8) - -
Neurological failure, n (%) - 9 (8.0) - -